Paracrine-stimulated gene expression profile favors estradiol production in breast tumors

被引:14
作者
Amin, Anober A.
Huang, Chiang-Ching
Reierstad, Scott
Lin, Zhihong
Arbieva, Zarema
Wiley, Elizabeth
Saborian, Hossain
Haynes, Ben
Cotterill, Helen
Dowsett, Mitch
Bulun, Serdar E. [1 ]
机构
[1] Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA
[3] Univ Illinois, Core Genom Facil, Res Resources Ctr, Chicago, IL 60607 USA
[4] Univ Illinois, Dept Pathol, Chicago, IL 60607 USA
[5] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75235 USA
[6] Royal Marsden Hosp, London SW3 6JJ, England
关键词
AKR1C3; aromatase; estrogen; breast cancer; breast adipose fibroblast; epithelial-stromal interaction;
D O I
10.1016/j.mce.2006.04.029
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Paracrine interactions between adipose fibroblasts and malignant epithelial cells are essential for structural and hormonal support of breast tumors. Factors derived from malignant epithelial cells inhibit adipogenic differentiation. of fibroblasts and upregulate expression of aromatase, which stimulates estrogen synthesis and creates a localized, growth-stimulatory environment. Here, we characterized the gene expression profile of breast adipose fibroblasts in an in vitro model of malignancy to identify other paracrine interactions that support tumor growth. Primary breast adipose fibroblasts from cancer-free women were treated with conditioned media from malignant breast epithelial cells or normal breast epithelial cells, and differences in gene expression were identified by microarray. A total of 79 differentially regulated genes encoding cytokines, enzymes, angiogenic factors, cytoskeletal proteins, extra-cellular matrix remodeling proteins, signal transduction proteins and cell surface receptors were identified, and 6 of these were verified by real-time PCR. Among these, the expression of aldo-keto reductase family 1, member C3 (AKR1C3) was upregulated. AKR1C3 has multiple enzymatic properties, including conversion of estrone to estradiol and androstenedione to testosterone. Immunoreactive AKR1C3 was detected in epithelial and stromal components of benign lesions and ductal carcinomas in situ, and in 59.8% of epithelial and 69.6% of stromal cells in invasive breast carcinomas. AKR1C3 expression was significantly higher in myoepithelial cells surrounding the neoplastic epithelium of ductal carcinoma in situ compared with those surrounding benign epithelial lesions. Importantly, AKR1C3 and aromatase mRNA levels correlated positively in 61 malignant breast tumors (R=0.3967, p=0.00156). Malignant epithelial cell-conditioned medium significantly increased formation of testosterone and estradiol from androstenedione in breast adipose fibroblasts. In conclusion, malignant epithelial cell-derived factors significantly upregulate the enzymes AKR1C3 and aromatase that catalyze a series of complementary reactions to convert the circulating precursor androstenedione to biologically active estradiol in vitro in the stromal fibroblasts, and in vivo, in stromal component of breast tumors. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:44 / 55
页数:12
相关论文
共 59 条
[1]   AROMATIZATION OF ANDROSTENEDIONE BY HUMAN ADIPOSE-TISSUE STROMAL CELLS IN MONOLAYER-CULTURE [J].
ACKERMAN, GE ;
SMITH, ME ;
MENDELSON, CR ;
MACDONALD, PC ;
SIMPSON, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (02) :412-417
[2]   Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients [J].
Agarwal, VR ;
Bulun, SE ;
Leitch, M ;
Rohrich, R ;
Simpson, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) :3843-3849
[3]   Molecular characterization of the tumor microenvironment in breast cancer [J].
Allinen, M ;
Beroukhim, R ;
Cai, L ;
Brennan, C ;
Lahti-Domenici, J ;
Huang, HY ;
Porter, D ;
Hu, M ;
Chin, L ;
Richardson, A ;
Schnitt, S ;
Sellers, WR ;
Polyak, K .
CANCER CELL, 2004, 6 (01) :17-32
[4]   Regulation of aromatase expression in estrogen-responsive breast and uterine disease: From bench to treatment [J].
Bulun, SE ;
Lin, ZH ;
Imir, G ;
Amin, S ;
Demura, M ;
Yilmaz, B ;
Martin, R ;
Utsunomiya, H ;
Thung, S ;
Gurates, B ;
Tamura, M ;
Langoi, D ;
Deb, S .
PHARMACOLOGICAL REVIEWS, 2005, 57 (03) :359-383
[5]   A LINK BETWEEN BREAST-CANCER AND LOCAL ESTROGEN BIOSYNTHESIS SUGGESTED BY QUANTIFICATION OF BREAST ADIPOSE-TISSUE AROMATASE CYTOCHROME-P450 TRANSCRIPTS USING COMPETITIVE POLYMERASE CHAIN-REACTION AFTER REVERSE TRANSCRIPTION [J].
BULUN, SE ;
PRICE, TM ;
AITKEN, J ;
MAHENDROO, MS ;
SIMPSON, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) :1622-1628
[6]   AROMATASE GENE-EXPRESSION IN ADIPOSE-TISSUE - RELATIONSHIP TO BREAST-CANCER [J].
BULUN, SE ;
MAHENDROO, MS ;
SIMPSON, ER .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 49 (4-6) :319-326
[7]   REGULATION OF AROMATASE EXPRESSION IN HUMAN TISSUES [J].
BULUN, SE ;
SIMPSON, ER .
BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (01) :19-29
[8]   Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes [J].
Clyne, CD ;
Speed, CJ ;
Zhou, J ;
Simpson, ER .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) :20591-20597
[9]   A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer [J].
Coombes, RC ;
Hall, E ;
Gibson, LJ ;
Paridaens, R ;
Jassem, J ;
Delozier, T ;
Jones, SE ;
Alvarez, I ;
Bertelli, G ;
Ortmann, O ;
Coates, AS ;
Bajetta, E ;
Dodwell, D ;
Coleman, RE ;
Fallowfield, LJ ;
Mickiewicz, E ;
Andersen, J ;
Lonning, PE ;
Cocconi, G ;
Stewart, A ;
Stuart, N ;
Snowdon, CF ;
Carpentieri, M ;
Massimini, G ;
Bliss, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) :1081-1092
[10]   Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells [J].
Crichton, MB ;
Nichols, JE ;
Zhao, Y ;
Bulun, SE ;
Simpson, ER .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 118 (1-2) :215-220